| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968527 | Vaccine | 2012 | 5 Pages |
Abstract
⺠An evaluation of Canadian-made AS03-adjuvanted H1N1pdm09 vaccine in adults. ⺠Evaluation included compatibility with trivalent inactivated influenza (TIV) vaccine. ⺠One dose of H1N1pdm09 vaccine (3.75 μg) was sufficiently immunogenic. ⺠Concurrent dosing did not adversely affect immune responses to either vaccine. ⺠Concurrent vaccinations did not increase rates of systemic symptoms.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
David W. Scheifele, Brian J. Ward, Marc Dionne, Otto G. Vanderkooi, Mark Loeb, Brenda L. Coleman, Yan Li, PHAC/CIHR Influenza Research Network (PCIRN) PHAC/CIHR Influenza Research Network (PCIRN),